PMID- 21191105 OWN - NLM STAT- MEDLINE DCOM- 20110420 LR - 20211203 IS - 1522-1563 (Electronic) IS - 0363-6143 (Linking) VI - 300 IP - 3 DP - 2011 Mar TI - Prostaglandin F2α stimulates PI3K/ERK/mTOR signaling and skeletal myotube hypertrophy. PG - C671-82 LID - 10.1152/ajpcell.00549.2009 [doi] AB - Cyclooxygenase (COX) enzymes mediate the synthesis of proinflammatory prostaglandin (PG) species from cellular arachidonic acid. COX/PGs have been implicated in skeletal muscle growth/regeneration; however, the mechanisms by which PGs influence skeletal muscle adaptation are poorly understood. The present study aimed to investigate PGF(2alpha) signaling and its role in skeletal myotube hypertrophy. PGF(2alpha) or the FP receptor agonist fluprostenol increased C2C12 myotube diameter. This effect was abolished by the FP receptor antagonist AL8810 and mammalian target of rapamycin (mTOR) inhibition. PGF(2alpha) stimulated time- and dose-dependent increases in the phosphorylation of extracellular receptor kinase (ERK)1/2 (Thr202/Tyr204), p70S6 kinase (p70S6K) (Thr389 and Thr421/Ser424), and eukaryotic initiation factor 4G (eIF4G) (Ser1108) without influencing Akt (Ser473). Pretreatment with the phosphoinositide 3-kinase (PI3K) inhibitor LY294002 and the ERK inhibitor PD98059 blocked F prostanoid receptor signaling responses, whereas rapamycin blocked heightened p70S6K/eIF4G phosphorylation without influencing ERK1/2 phosphorylation. These data suggest that activation of the F prostanoid receptor is coupled to C2C12 myotube growth and intracellular signaling via a PI3K/ERK/mTOR-dependent pathway. FAU - Markworth, James F AU - Markworth JF AD - School of Exercise and Nutrition Sciences, Deakin Univ., 221 Burwood Highway, Burwood, Victoria 3125, Australia. FAU - Cameron-Smith, David AU - Cameron-Smith D LA - eng PT - Journal Article DEP - 20101229 PL - United States TA - Am J Physiol Cell Physiol JT - American journal of physiology. Cell physiology JID - 100901225 RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) SB - IM MH - Animals MH - Cell Differentiation/physiology MH - Cell Line MH - Cell Movement/physiology MH - Extracellular Signal-Regulated MAP Kinases/*physiology MH - Hypertrophy MH - MAP Kinase Signaling System/physiology MH - Mice MH - Muscle Fibers, Skeletal/enzymology/*metabolism/pathology MH - Muscle, Skeletal/enzymology/*metabolism/*pathology MH - Myoblasts/enzymology/metabolism/pathology MH - Phosphatidylinositol 3-Kinases/*physiology MH - Signal Transduction/*physiology MH - TOR Serine-Threonine Kinases/*physiology EDAT- 2010/12/31 06:00 MHDA- 2011/04/22 06:00 CRDT- 2010/12/31 06:00 PHST- 2010/12/31 06:00 [entrez] PHST- 2010/12/31 06:00 [pubmed] PHST- 2011/04/22 06:00 [medline] AID - ajpcell.00549.2009 [pii] AID - 10.1152/ajpcell.00549.2009 [doi] PST - ppublish SO - Am J Physiol Cell Physiol. 2011 Mar;300(3):C671-82. doi: 10.1152/ajpcell.00549.2009. Epub 2010 Dec 29.